*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter - as a primary diagnosis code | T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 4.64 | |
| Readmission Rate (%) | 22.52 | |
| Unplanned Readmission Rate (%) | 20.61 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|
| Total Hospitalizations at DRG | 71,748 | |
| Total Hospitalizations with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 78 | |
| DRG Share of Total Hospitalizations | 0.22 | |
| % of Total ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter in DRG | 56.52 | |
| Avg LOS at DRG | 2.93 | |
| Avg LOS with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 2.32 | |
| Readmission Rate at DRG | 33.86 | |
| Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 18.92 | |
| Unplanned Readmission Rate at DRG | 10.34 | |
| Unplanned Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 17.57 | |
| Total Medicare payments at DRG | $313,351,773 | |
| Total Medicare payments with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $327,728 | |
| Total Medicare payment per Day at DRG | $1,489 | |
| Total Medicare payment per Day with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $1,811 | |
| Total Medicare payment per Hospitalization at DRG | $4,367 | |
| Total Medicare payment per Hospitalization with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $4,202 | |
| Total Medicare Charges at DRG | $1,750,048,705 | |
| Total Medicare Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $1,544,780 | |
| Avg Charges at DRG | $24,392 | |
| Avg Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $19,805 | |
| Mortality Rate at DRG | 0.22 | |
| Mortality Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | NA | |
| SNF Discharge Rate at DRG | 7.61 | |
| SNF Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | NA | |
| Home Discharge Rate at DRG | 51.88 | |
| Home Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 65.38 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 637: DIABETES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 639: DIABETES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 174,196 | ||||
| Total Hospitalizations with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 4,592 | ||||
| DRG Share of Total Hospitalizations | 0.53 | ||||
| % of Total ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter in DRG | 14.98 | ||||
| Avg LOS at DRG | 3.86 | ||||
| Avg LOS with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 2.99 | ||||
| Readmission Rate at DRG | 23.62 | ||||
| Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 21.65 | ||||
| Unplanned Readmission Rate at DRG | 17.61 | ||||
| Unplanned Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 16.65 | ||||
| Total Medicare payments at DRG | $959,872,570 | ||||
| Total Medicare payments with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $24,686,627 | ||||
| Total Medicare payment per Day at DRG | $1,426 | ||||
| Total Medicare payment per Day with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $1,799 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,510 | ||||
| Total Medicare payment per Hospitalization with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $5,376 | ||||
| Total Medicare Charges at DRG | $4,945,131,055 | ||||
| Total Medicare Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $117,826,002 | ||||
| Avg Charges at DRG | $28,388 | ||||
| Avg Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $25,659 | ||||
| Mortality Rate at DRG | 0.24 | ||||
| Mortality Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 14.83 | ||||
| SNF Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 19.58 | ||||
| Home Discharge Rate at DRG | 53.93 | ||||
| Home Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 49.93 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 365,119 | ||||
| Total Hospitalizations with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 1,158 | ||||
| DRG Share of Total Hospitalizations | 1.11 | ||||
| % of Total ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter in DRG | 3.78 | ||||
| Avg LOS at DRG | 5.91 | ||||
| Avg LOS with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 5.97 | ||||
| Readmission Rate at DRG | 27.73 | ||||
| Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 26.82 | ||||
| Unplanned Readmission Rate at DRG | 20.3 | ||||
| Unplanned Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 17.63 | ||||
| Total Medicare payments at DRG | $3,552,910,533 | ||||
| Total Medicare payments with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $11,404,422 | ||||
| Total Medicare payment per Day at DRG | $1,646 | ||||
| Total Medicare payment per Day with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $1,650 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,731 | ||||
| Total Medicare payment per Hospitalization with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $9,848 | ||||
| Total Medicare Charges at DRG | $16,860,985,198 | ||||
| Total Medicare Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $57,627,455 | ||||
| Avg Charges at DRG | $46,179 | ||||
| Avg Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $49,765 | ||||
| Mortality Rate at DRG | 5.06 | ||||
| Mortality Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 3.8 | ||||
| SNF Discharge Rate at DRG | 28.7 | ||||
| SNF Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 24.61 | ||||
| Home Discharge Rate at DRG | 32.16 | ||||
| Home Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 37.91 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 644: ENDOCRINE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 643: ENDOCRINE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 440: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 85,343 | ||||
| Total Hospitalizations with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 478 | ||||
| DRG Share of Total Hospitalizations | 0.26 | ||||
| % of Total ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter in DRG | 1.56 | ||||
| Avg LOS at DRG | 3.89 | ||||
| Avg LOS with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 3.69 | ||||
| Readmission Rate at DRG | 21.05 | ||||
| Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 14.81 | ||||
| Unplanned Readmission Rate at DRG | 15.83 | ||||
| Unplanned Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 10.46 | ||||
| Total Medicare payments at DRG | $457,925,564 | ||||
| Total Medicare payments with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $2,440,956 | ||||
| Total Medicare payment per Day at DRG | $1,380 | ||||
| Total Medicare payment per Day with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $1,384 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,366 | ||||
| Total Medicare payment per Hospitalization with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $5,107 | ||||
| Total Medicare Charges at DRG | $2,522,082,455 | ||||
| Total Medicare Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $14,165,380 | ||||
| Avg Charges at DRG | $29,552 | ||||
| Avg Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $29,635 | ||||
| Mortality Rate at DRG | 0.3 | ||||
| Mortality Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 5.52 | ||||
| SNF Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 5.44 | ||||
| Home Discharge Rate at DRG | 75.74 | ||||
| Home Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 84.52 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | DRG 312: SYNCOPE AND COLLAPSE | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 474,314 | ||||
| Total Hospitalizations with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 312 | ||||
| DRG Share of Total Hospitalizations | 1.44 | ||||
| % of Total ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter in DRG | 1.02 | ||||
| Avg LOS at DRG | 3.53 | ||||
| Avg LOS with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 3.43 | ||||
| Readmission Rate at DRG | 18.03 | ||||
| Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 19.06 | ||||
| Unplanned Readmission Rate at DRG | 12.55 | ||||
| Unplanned Readmission Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 14.05 | ||||
| Total Medicare payments at DRG | $2,312,733,090 | ||||
| Total Medicare payments with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $1,513,244 | ||||
| Total Medicare payment per Day at DRG | $1,380 | ||||
| Total Medicare payment per Day with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $1,416 | ||||
| Total Medicare payment per Hospitalization at DRG | $4,876 | ||||
| Total Medicare payment per Hospitalization with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $4,850 | ||||
| Total Medicare Charges at DRG | $11,559,952,314 | ||||
| Total Medicare Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $7,713,384 | ||||
| Avg Charges at DRG | $24,372 | ||||
| Avg Charges with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | $24,722 | ||||
| Mortality Rate at DRG | 0.22 | ||||
| Mortality Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | NA | ||||
| SNF Discharge Rate at DRG | 25.96 | ||||
| SNF Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 24.68 | ||||
| Home Discharge Rate at DRG | 43.58 | ||||
| Home Discharge Rate with ICD T383X5A - Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter | 44.23 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| JEFFERSON STRATFORD HOSPITAL | 18 E LAUREL RD | STRATFORD | NJ | 08084 | 112 |
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 105 |
| MONTEFIORE MEDICAL CENTER | 111 E 210TH ST | BRONX | NY | 10467 | 90 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. ZIAD SOUS | 1145 S UTICA AVE | TULSA | OK | 74104 | 24 |
| Dr. ROBERT BRIAN HIGHTOWER | 1025 E 2ND ST | CUSHING | OK | 74023 | 20 |
| Dr. SHAKTI DAYAL SRIVASTAVA | 1401 GARCES HWY | DELANO | CA | 93215 | 13 |